Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-04 4:15 pm Purchase | 2025-06-30 | 13G | BIORA THERAPEUTICS INC PAR BIORQ | M.H. DAVIDSON & CO. | 906,227 9.900% | 906,227 (New Position) | Filing History |
| 2025-08-04 08:00 am Purchase | 2025-04-07 | 13G | BIORA THERAPEUTICS INC PAR BIORQ | TAGGETT MARGARET ELLEN | 297,000 6.600% | 297,000 (New Position) | Filing History |
| 2025-07-10 09:51 am Purchase | 2025-06-30 | 13G | BIORA THERAPEUTICS INC PAR BIORQ | Context Capital Management LLC | 22,025 0.500% | 22,025 (New Position) | Filing History |
| 2025-03-26 9:30 pm Purchase | 2025-03-24 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 3,416,032 49.900% | 841,579 (+32.69%) | Filing History |
| 2024-11-14 10:01 am Purchase | 2024-09-30 | 13G | BIORA THERAPEUTICS INC PAR BIORQ | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 19,958,480 9.990% | 19,958,480 (New Position) | Filing History |
| 2024-10-09 5:40 pm Purchase | 2024-10-07 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 2,574,453 49.900% | 30,716 (+1.21%) | Filing History |
| 2024-09-13 10:37 am Unchanged | 2024-09-10 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 2,543,737 49.900% | 0 (Unchanged) | Filing History |
| 2024-08-20 4:15 pm Purchase | 2023-12-19 | 13G | Biora Therapeutics, Inc. BIOR | M.H. DAVIDSON & CO. | 3,731,590 9.900% | 3,731,590 (New Position) | Filing History |
| 2024-08-14 9:58 pm Purchase | 2024-08-12 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 2,543,737 49.900% | 58,291 (+2.35%) | Filing History |
| 2024-07-08 9:42 pm Purchase | 2024-07-03 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 2,485,446 49.900% | 2,485,446 (New Position) | Filing History |
| 2024-04-02 8:43 pm Purchase | 2024-03-31 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 1,930,628 49.900% | 309,176 (+19.07%) | Filing History |
| 2024-03-20 6:29 pm Purchase | 2024-03-12 | 13G | Biora Therapeutics, Inc. BIOR | Context Capital Management LLC | 298,970 9.900% | 298,970 (New Position) | Filing History |
| 2024-02-14 2:43 pm Purchase | 2023-12-31 | 13G | Biora Therapeutics, Inc. BIOR | Armistice Capital, LLC | 107,490 3.800% | 107,490 (New Position) | Filing History |
| 2023-12-20 4:35 pm Purchase | 2023-12-18 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 1,621,453 49.900% | 386,569 (+31.30%) | Filing History |
| 2023-09-19 4:15 pm Purchase | 2023-09-18 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 1,234,884 49.900% | 867,926 (+236.52%) | Filing History |
| 2023-03-13 4:18 pm Purchase | 2023-03-10 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 366,958 32.700% | 82,414 (+28.96%) | Filing History |
| 2023-02-14 12:05 pm Purchase | 2022-12-31 | 13G | Biora Therapeutics, Inc. BIOR | Armistice Capital, LLC | 1,298,965 5.700% | 1,298,965 (New Position) | Filing History |
| 2023-01-12 4:46 pm Purchase | 2023-01-03 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 284,544 27.800% | 0 (+0.00%) | Filing History |
| 2022-11-18 4:30 pm Purchase | 2022-11-09 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 284,544 28.400% | 16,036 (+5.97%) | Filing History |
| 2022-02-14 3:32 pm Purchase | 2021-12-31 | 13G | Biora Therapeutics, Inc. BIOR | CVI Investments, Inc. | 15,000 2.200% | 15,000 (New Position) | Filing History |